Carotid stent fractures are not associated with adverse events results from the ACT-1 multicenter randomized trial (carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with signifcant extracranial carotid stenotic disease)

Ido Weinberg, Joshua A. Beckman, Jon S. Matsumura, Kenneth Rosenfeld, Gary M. Ansel, Seemant Chaturvedi, William Gray, D. Chris Metzger, Tom Riles, Yu Shu, Lawrence Wechsler, Michael R. Jaff

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: The impact of carotid artery stent fractures on the incidence of adverse clinical events remains unclear. The objective of this study is to report the stent fracture rate and its association with in-stent restenosis and adverse outcomes in the ACT-1 trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Signifcant Extracranial Carotid Stenotic Disease). METHODS: ACT-1 is a prospective multicenter trial of patients who have standard surgical risk with severe asymptomatic carotid artery stenosis randomly assigned to carotid artery stenting or carotid endarterectomy (Abbott Vascular). The primary end point was a composite of death, stroke, or myocardial infarction during the 30 days after the procedure or ipsilateral stroke during the 365 days after the procedure. After 771 patients were enrolled, successively randomly assigned patients were required to undergo annual radiographic (X-ray) analysis for stent fracture. Images were independently adjudicated by a core laboratory. RESULTS: Of 1021 patients treated with carotid artery stenting during a mean follow-up of 3.1±1.6 years, 939 had at least 1 X-ray during the follow-up period. Stent fracture was reported in 51 (5.4%) patients. With a maximum follow-up period of 5 years, adverse clinical outcomes occurred in 39 patients with at least 1 X-ray during the follow-up. Of 826 (80.9%) subjects who underwent both duplex ultrasound and X-ray, 822 (99.5%) were interpretable. There was no association between stent fracture and the primary end point (P=0.86) or with restenosis (P=0.53). CONCLUSIONS: In this large, independently adjudicated, multicenter study, the stent fracture rate was low and not associated with major adverse clinical events or in-stent restenosis.

Original languageEnglish (US)
Pages (from-to)49-56
Number of pages8
JournalCirculation
Volume137
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Endarterectomy
Carotid Endarterectomy
Angioplasty
Multicenter Studies
Stents
Carotid Arteries
X-Rays
Stroke
Carotid Stenosis
Blood Vessels
Myocardial Infarction
Incidence

Keywords

  • Carotid arteries
  • Carotid stenosis
  • Carotid stent fracture
  • Endarterectomy, carotid
  • Myocardial infarction
  • Stents
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Carotid stent fractures are not associated with adverse events results from the ACT-1 multicenter randomized trial (carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with signifcant extracranial carotid stenotic disease). / Weinberg, Ido; Beckman, Joshua A.; Matsumura, Jon S.; Rosenfeld, Kenneth; Ansel, Gary M.; Chaturvedi, Seemant; Gray, William; Chris Metzger, D.; Riles, Tom; Shu, Yu; Wechsler, Lawrence; Jaff, Michael R.

In: Circulation, Vol. 137, No. 1, 01.01.2018, p. 49-56.

Research output: Contribution to journalArticle

Weinberg, Ido ; Beckman, Joshua A. ; Matsumura, Jon S. ; Rosenfeld, Kenneth ; Ansel, Gary M. ; Chaturvedi, Seemant ; Gray, William ; Chris Metzger, D. ; Riles, Tom ; Shu, Yu ; Wechsler, Lawrence ; Jaff, Michael R. / Carotid stent fractures are not associated with adverse events results from the ACT-1 multicenter randomized trial (carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with signifcant extracranial carotid stenotic disease). In: Circulation. 2018 ; Vol. 137, No. 1. pp. 49-56.
@article{809d43ef64d841b18df204955cdb1cbd,
title = "Carotid stent fractures are not associated with adverse events results from the ACT-1 multicenter randomized trial (carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with signifcant extracranial carotid stenotic disease)",
abstract = "Background: The impact of carotid artery stent fractures on the incidence of adverse clinical events remains unclear. The objective of this study is to report the stent fracture rate and its association with in-stent restenosis and adverse outcomes in the ACT-1 trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Signifcant Extracranial Carotid Stenotic Disease). METHODS: ACT-1 is a prospective multicenter trial of patients who have standard surgical risk with severe asymptomatic carotid artery stenosis randomly assigned to carotid artery stenting or carotid endarterectomy (Abbott Vascular). The primary end point was a composite of death, stroke, or myocardial infarction during the 30 days after the procedure or ipsilateral stroke during the 365 days after the procedure. After 771 patients were enrolled, successively randomly assigned patients were required to undergo annual radiographic (X-ray) analysis for stent fracture. Images were independently adjudicated by a core laboratory. RESULTS: Of 1021 patients treated with carotid artery stenting during a mean follow-up of 3.1±1.6 years, 939 had at least 1 X-ray during the follow-up period. Stent fracture was reported in 51 (5.4{\%}) patients. With a maximum follow-up period of 5 years, adverse clinical outcomes occurred in 39 patients with at least 1 X-ray during the follow-up. Of 826 (80.9{\%}) subjects who underwent both duplex ultrasound and X-ray, 822 (99.5{\%}) were interpretable. There was no association between stent fracture and the primary end point (P=0.86) or with restenosis (P=0.53). CONCLUSIONS: In this large, independently adjudicated, multicenter study, the stent fracture rate was low and not associated with major adverse clinical events or in-stent restenosis.",
keywords = "Carotid arteries, Carotid stenosis, Carotid stent fracture, Endarterectomy, carotid, Myocardial infarction, Stents, Stroke",
author = "Ido Weinberg and Beckman, {Joshua A.} and Matsumura, {Jon S.} and Kenneth Rosenfeld and Ansel, {Gary M.} and Seemant Chaturvedi and William Gray and {Chris Metzger}, D. and Tom Riles and Yu Shu and Lawrence Wechsler and Jaff, {Michael R.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1161/CIRCULATIONAHA.117.030030",
language = "English (US)",
volume = "137",
pages = "49--56",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Carotid stent fractures are not associated with adverse events results from the ACT-1 multicenter randomized trial (carotid angioplasty and stenting versus endarterectomy in asymptomatic subjects who are at standard risk for carotid endarterectomy with signifcant extracranial carotid stenotic disease)

AU - Weinberg, Ido

AU - Beckman, Joshua A.

AU - Matsumura, Jon S.

AU - Rosenfeld, Kenneth

AU - Ansel, Gary M.

AU - Chaturvedi, Seemant

AU - Gray, William

AU - Chris Metzger, D.

AU - Riles, Tom

AU - Shu, Yu

AU - Wechsler, Lawrence

AU - Jaff, Michael R.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: The impact of carotid artery stent fractures on the incidence of adverse clinical events remains unclear. The objective of this study is to report the stent fracture rate and its association with in-stent restenosis and adverse outcomes in the ACT-1 trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Signifcant Extracranial Carotid Stenotic Disease). METHODS: ACT-1 is a prospective multicenter trial of patients who have standard surgical risk with severe asymptomatic carotid artery stenosis randomly assigned to carotid artery stenting or carotid endarterectomy (Abbott Vascular). The primary end point was a composite of death, stroke, or myocardial infarction during the 30 days after the procedure or ipsilateral stroke during the 365 days after the procedure. After 771 patients were enrolled, successively randomly assigned patients were required to undergo annual radiographic (X-ray) analysis for stent fracture. Images were independently adjudicated by a core laboratory. RESULTS: Of 1021 patients treated with carotid artery stenting during a mean follow-up of 3.1±1.6 years, 939 had at least 1 X-ray during the follow-up period. Stent fracture was reported in 51 (5.4%) patients. With a maximum follow-up period of 5 years, adverse clinical outcomes occurred in 39 patients with at least 1 X-ray during the follow-up. Of 826 (80.9%) subjects who underwent both duplex ultrasound and X-ray, 822 (99.5%) were interpretable. There was no association between stent fracture and the primary end point (P=0.86) or with restenosis (P=0.53). CONCLUSIONS: In this large, independently adjudicated, multicenter study, the stent fracture rate was low and not associated with major adverse clinical events or in-stent restenosis.

AB - Background: The impact of carotid artery stent fractures on the incidence of adverse clinical events remains unclear. The objective of this study is to report the stent fracture rate and its association with in-stent restenosis and adverse outcomes in the ACT-1 trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Signifcant Extracranial Carotid Stenotic Disease). METHODS: ACT-1 is a prospective multicenter trial of patients who have standard surgical risk with severe asymptomatic carotid artery stenosis randomly assigned to carotid artery stenting or carotid endarterectomy (Abbott Vascular). The primary end point was a composite of death, stroke, or myocardial infarction during the 30 days after the procedure or ipsilateral stroke during the 365 days after the procedure. After 771 patients were enrolled, successively randomly assigned patients were required to undergo annual radiographic (X-ray) analysis for stent fracture. Images were independently adjudicated by a core laboratory. RESULTS: Of 1021 patients treated with carotid artery stenting during a mean follow-up of 3.1±1.6 years, 939 had at least 1 X-ray during the follow-up period. Stent fracture was reported in 51 (5.4%) patients. With a maximum follow-up period of 5 years, adverse clinical outcomes occurred in 39 patients with at least 1 X-ray during the follow-up. Of 826 (80.9%) subjects who underwent both duplex ultrasound and X-ray, 822 (99.5%) were interpretable. There was no association between stent fracture and the primary end point (P=0.86) or with restenosis (P=0.53). CONCLUSIONS: In this large, independently adjudicated, multicenter study, the stent fracture rate was low and not associated with major adverse clinical events or in-stent restenosis.

KW - Carotid arteries

KW - Carotid stenosis

KW - Carotid stent fracture

KW - Endarterectomy, carotid

KW - Myocardial infarction

KW - Stents

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85047774249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047774249&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.117.030030

DO - 10.1161/CIRCULATIONAHA.117.030030

M3 - Article

VL - 137

SP - 49

EP - 56

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 1

ER -